Form 4 for DOW Dow Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001751788-24-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-20 | 2024-02-16 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | G - Gift | $0.00 | +2,341 | 53.7K | +5% | $0 |
| DM | 2024-02-20 | 2024-02-16 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | M - OptEx | $48.98 | +27.9K | 25.7K | New | +$1.37M |
| D | 2024-02-20 | 2024-02-16 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | G - Gift | $0.00 | -2,341 | 15.5K | -13% | $0 |
| DM | 2024-02-20 | 2024-02-16 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | D - Sale to Iss | $55.62 | -25.6K | 16.9K | -60% | -$1.42M |
| D | 2024-02-20 | 2024-02-15 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | A - Grant | $0.00 | +5,450 | 15.5K | +54% | $0 |
| DM | 2024-02-20 | 2024-02-16 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | M - OptEx | $0.00 | -27.9K | 12.5K | -69% | $0 |
| D | 2024-02-20 | 2024-02-15 | DOW | Gregorio Mauro | Pres, Perf Mat, Coatings | A - Grant | $0.00 | +36.6K | 36.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | G | A | 2,341 | $0.00 | 53,679 | I | — | — | |
| 2 | Common | Common Stock | 2024-02-16 | M | A | 19,133 | $50.07 | 34,682 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-16 | G | D | 2,341 | $0.00 | 15,549 | D | — | — | (F5) Total includes previously reported restricted stock units. |
| 4 | Common | Common Stock | 2024-02-16 | D | D | 7,800 | $55.63 | 17,890 | D | — | — | (F2) Shares used to satisfy the exercise price and tax withholding of the Reporting Person upon exercise of options as required by the award agreement and exempt under Rule 16b-3. (F4) The price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.605 to $55.631. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-02-16 | M | A | 8,800 | $46.60 | 25,690 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-16 | D | D | 17,792 | $55.61 | 16,890 | D | — | — | (F2) Shares used to satisfy the exercise price and tax withholding of the Reporting Person upon exercise of options as required by the award agreement and exempt under Rule 16b-3. (F3) The price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.560 to $55.601. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2024-02-15 | A | A | 5,450 | $0.00 | 15,549 | D By Trust | — | — | (F1) Restricted stock units to be delivered in one installment on or about February 15, 2027, subject to continued employment. |
| 8 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-02-16 | M | D | 19,133 | $0.00 | 0 | D | $50.07 · — to 2025-02-13 | 19,133 Common Stock | (F7) This option is fully vested and exercisable. |
| 9 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-02-15 | A | A | 36,600 | $0.00 | 36,600 | D | $55.17 · — to 2034-02-15 | 36,600 Common Stock | (F6) This option will vest in three equal installments beginning on February 15, 2025. Option shares will be used to satisfy withholding taxes. |
| 10 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-02-16 | M | D | 8,800 | $0.00 | 12,505 | D | $46.60 · — to 2026-02-12 | 8,800 Common Stock | (F7) This option is fully vested and exercisable. |